Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies
S Sloot, YA Chen, X Zhao, JL Weber, JJ Benedict… - Cancer, 2018 - Wiley Online Library
BACKGROUND The development of brain metastases is common for systemic treatment
failure in patients with melanoma and has been associated with a poor prognosis. Recent …
failure in patients with melanoma and has been associated with a poor prognosis. Recent …
Improved Survival of Patients With Melanoma Brain Metastases in the Era of Targeted BRAF and Immune Checkpoint Therapies
S Sloot, YA Chen, X Zhao, JL Weber, JJ Benedict… - Cancer, 2018 - research.rug.nl
BACKGROUND: The development of brain metastases is common for systemic treatment
failure in patients with melanoma and has been associated with a poor prognosis. Recent …
failure in patients with melanoma and has been associated with a poor prognosis. Recent …
[HTML][HTML] Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies
S Sloot, YA Chen, X Zhao, J Weber, JJ Benedict… - Cancer, 2018 - ncbi.nlm.nih.gov
BACKGROUND: The development of brain metastases is common for systemic treatment
failure in melanoma patients and has been associated with a poor prognosis. Recent …
failure in melanoma patients and has been associated with a poor prognosis. Recent …
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies
S Sloot, YA Chen, X Zhao, JL Weber, JJ Benedict… - Cancer, 2018 - pubmed.ncbi.nlm.nih.gov
Background The development of brain metastases is common for systemic treatment failure
in patients with melanoma and has been associated with a poor prognosis. Recent …
in patients with melanoma and has been associated with a poor prognosis. Recent …
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
S Sloot, YA Chen, X Zhao, JL Weber, JJ Benedict… - Cancer, 2017 - europepmc.org
Background The development of brain metastases is common for systemic treatment failure
in patients with melanoma and has been associated with a poor prognosis. Recent …
in patients with melanoma and has been associated with a poor prognosis. Recent …
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
S Sloot, YA Chen, X Zhao, JL Weber, JJ Benedict… - Cancer, 2017 - europepmc.org
Background The development of brain metastases is common for systemic treatment failure
in patients with melanoma and has been associated with a poor prognosis. Recent …
in patients with melanoma and has been associated with a poor prognosis. Recent …